"Galectin-3 as a Marker of Subclinical Inflammation in FMF"

The goal of this observational study is to learn about the relationship between serum Galectin-3 levels and subclinical inflammation in patients with Familial Mediterranean Fever (FMF). The main questions it aims to answer are: * Are serum Galectin-3 levels higher in FMF patients compared to healthy controls? * Is there a positive correlation between serum Galectin-3 levels and Serum Amyloid A (SAA) protein levels in FMF patients? Participants will: * Provide blood samples to measure serum Galectin-3 and SAA levels. * Complete a sociodemographic and clinical data form. * Fill out the FMF Quality of Life (QoL) scale. Researchers will compare FMF patients and healthy controls to see if there are significant differences in serum Galectin-3 levels and to determine the correlation between Galectin-3 and SAA protein levels in FMF patients.